Iannone Robert
EVP, Global Head of R&D & CMO
Iannone Robert has filed 6 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 31, 2026.
On the most recent filing, Iannone Robert is listed as EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals plc. Inside the rolling window, Iannone Robert reported no open-market purchases and 2 open-market sales totaling $20.4M in JAZZ. The largest disclosed transaction in the window is a sale of 76,921 JAZZ shares on Aug 27, 2026, worth $19.2M.
Companies traded
Other insiders at JAZZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$20.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Iannone Robert made?
Iannone Robert has filed 6 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Iannone Robert trade?
Iannone Robert has filed SEC Form 4 disclosures for 1 company, including JAZZ.
When was Iannone Robert's most recent SEC Form 4 filing?
Iannone Robert's most recent SEC Form 4 filing on Tracefour is dated Aug 31, 2026.
What is Iannone Robert's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Iannone Robert is listed as EVP, Global Head of R&D & CMO.
What is Iannone Robert's total buy and sell value in the current window?
Inside the rolling retention window, Iannone Robert bought $0 and sold $20.4M based on SEC Form 4 filings.
What was Iannone Robert's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 76,921 JAZZ shares on 2026-08-27, worth $19.2M, per SEC Form 4 filings.